arrow). Asterisk in (G) denotes area magnified in (H). Scale bar: 250 m for (A), (C), (E), (G), and (I); 50 m for (B), (D), (F), (H), and (J).
possess both a peripheral branch that innervates the hindfasciculus by injecting an anatomical tracer (the ␤ subunit of cholera toxin conjugated to horseradish peroxilimb as well as a central branch that courses in the gracile fasciculus (the most medial component of the dorsal dase [B-HRP]) into the sciatic nerve. This tracer is taken up selectively by medium and large diameter myelinated columns) and terminates in the gracile nucleus in the medulla ( Figure 1B) . We visualized axons in the gracile axons (Robertson and Grant, 1989) and transported ret-2). This small amount of growth may result from injury during injection mimicking the effect of a conditioning lesion (see Discussion). In contrast to the results from these control groups, when we microinjected L4/L5 DRGs with db-cAMP (1.5 l of a 10 mM solution injected in each ganglion) 48 hr prior to dorsal column lesion, we observed a robust regenerative response. In all cases analyzed (n ϭ 6), massive numbers of damaged fibers penetrated and regenerated into and across the lesion site ( Figures 1G-1J ). As shown in Figure 2 , the length of the fibers was much longer than observed in controls. A prominent feature of the regenerating fibers was a loss of the fasciculation typical of intact dorsal column fibers ( Figures 1H and 1J) . Some of the fibers in the (saline injected; Figures 4B and 4E) (p Ͻ 0.02, Student's t We next examined more specifically whether the in test). However, the distribution of neurite lengths among vivo manipulation we had performed, the injection of neurite-bearing neurons was not markedly changed db-cAMP into DRG, also results in an enhancement of ( Figure 4F ). The slight difference between control and the growth properties of the neurites of those neurons.
saline-treated groups parallels the slight difference obFor this, we unilaterally injected the L4 and L5 ganglia served in vivo (Figures 1 and 2) . In contrast to the very with db-cAMP; 48 hr later, the rats were killed, the inpoor growth observed in these control groups, after 18 jected and the contralateral noninjected (control) L4 and hr we observed extensive growth of N-52ϩ neurites from L5 sensory ganglia were separately pooled and dissocineurons treated in vivo with db-cAMP ( Figure 4C ), as ated, and the neurons were plated on poly-D-lysine.
49.7% Ϯ 4.3% of neurons now had neurites ( Figure 4E ) As a further control, we cultured neurons from ganglia (p Ͻ 0.0001 for comparison with either saline treatment injected with saline. In a previous study, Smith and or control). Furthermore, the length of the neurites was Skene showed that when control adult sensory neurons significantly increased: for example, the fraction of all are cultured on a permissive substrate, there is a 20-24 N-52ϩ neurons in the cultures with neurites greater than hr lag before they extend neurites in a significant way, 250 m in length increased from 0.1% Ϯ 0.05% and but that this time can be shortened if neurons are sub-0.85% Ϯ 0.2% for control or saline-treated conditions, jected to peripheral nerve injury 2-7 days before plating respectively, to 6.5% Ϯ 0.7% for the db-cAMP-treated (Smith and Skene, 1997). We therefore chose to examine condition (p Ͻ 0.0003). This increase did not merely the neurons after 18 hr in culture, to determine whether, reflect the fact that more neurons had neurites in the as with the conditioning lesion, the pretreatment with db-cAMP-treated case, but also reflected the fact that db-cAMP could affect the timing of onset and/or rate neurites that extended from these neurons were longer of extension of the axons. than in controls. This was shown by the analysis of As expected, little outgrowth was observed after 18 Figure 4F , in which we focused only on neurons with neurites (processes Ͼ 30 m), a procedure that will tend hr from N-52ϩ neurons from noninjected ganglia (Fig-Figure 4 Figure 4E ) (p Ͼ 0.4). Again, when we focused just on neurons with to control or saline-treated; Figure 4F) . Thus, the dbcAMP treatment increases both the number of processneurites greater than 30 m in length, there was also a significant increase in the lengths of neurites compared bearing cells at 18 hr, as well as the lengths of neurites of those cells.
to control and saline-injected groups ( Figures 4D and  4E) , including a significant increase in the number of Our finding that a large fraction (50%) of the neurons exposed to db-cAMP extended neurites in vitro at 18 neurons with neurites greater than 250 m ( Figure 4F) (p Ͻ 0.003, when compared to either control or salineagain more than doubled compared to control or salineinjected [p Ͻ 0.002 in both cases]). injected). Although the trend appeared to be that neurite lengths were slightly greater after the conditioning lesion treatment than after the db-cAMP treatment, the differDiscussion ences between the two groups were not significant (p Ͼ 0.14 for each neurite length bin).
Our results show that injection of db-cAMP into adult sensory ganglia prior to lesioning their central processes can endow the treated sensory neurons with the ability Enhanced Outgrowth of Neurites on an Inhibitory Substrate after Injection of db-cAMP into DRGs to regenerate injured axons into the adult CNS in vivo. Based on our in vitro results, we suggest that there are Because the environment in which sensory axons regenerate after CNS injury is inhibitory, we next asked two key mechanisms through which stimulation of cAMP signaling promotes in vivo regeneration: increasing the whether cAMP pretreatment in vivo could also subsequently enable the neurons to extend neurites on an intrinsic growth capacity of the axons (manifested by an earlier onset of robust axon outgrowth) and enabling inhibitory substrate. Dissociated L4/L5 sensory neurons obtained from rats injected as above with db-cAMP them to overcome the effects of inhibitory factors at the lesion site. (Strictly speaking, in our in vitro studies we were plated on a substrate of poly-D-lysine and myelin, a well-known inhibitory substrate (Schwab and Caroni, showed that the cyclic nucleotide treatment can overcome the inhibitory effect of myelin, and for technical 1988). Because normal growth is significantly attenuated on the myelin substrate, in these experiments, we reasons we did not test its ability to overcome inhibition by injury site tissue, but the fact that regeneration occurs assessed neurite outgrowth after 36 hr rather than after 18 hr in culture. At 36 hr, virtually no outgrowth was through that tissue in vivo supports the possibility that the treatment is overcoming inhibition there as well.) observed from noninjected N-52ϩ neurons (Figures 5A, 5E, and 5F). As on a permissive substrate, when N-52ϩ
Despite the profuse outgrowth of neurites into the lesion site, in this particular paradigm we did not observe neurons from saline-injected neurons were grown on a myelin substrate, we also observed a very slight but growth rostral to the lesion site, as has been observed when a sciatic nerve lesion is made 1 week prior to the statistically significant increase in the number of neurons with neurites, from 4.6% Ϯ 1.0% to 8.5% Ϯ 1.3% dorsal column lesion. Because we used only one dose of db-cAMP and one time point, it is conceivable that ( Figures 5B and 5E We have not assessed whether the cAMP treatment also affects the growth of the peripheral branch in vivo. strate, this increase did not merely reflect the fact that more neurons had neurites, but also reflected the fact The parallels between the effects of db-cAMP injection into DRG and the effects of a conditioning peripheral that neurites that extended from these neurons were longer than in controls. This was shown by the analysis nerve lesion are striking. Each manipulation increases the intrinsic growth capacity of sensory neurons, such of Figure 5F , in which we focused just on the neurons with neurites greater than 30 m. Even within those that they extend axons more rapidly when placed in culture. Each manipulation also promotes an increased populations, there was also a statistically significant increase (more than double) in the fraction of neurons rate of extension of the axons on a permissive substrate and an ability to counteract the inhibitory effects of mywith neurites greater than 150 m in the db-cAMPtreated case compared to control or saline-injected (p Ͻ elin. Each of these factors, we believe, contributes to our most important finding, namely that either the condi-0.005 in both cases). As was perhaps expected, similar results were obtained for neurons derived from rats subtioning lesion or direct injection of db-cAMP into the DRG allows for profuse regeneration of the central jected to a conditioning sciatic nerve lesion, when cultured on myelin: we observed a statistically significant branches of injured sensory axons through a spinal cord lesion site. Based on these parallels, we propose that increase in the number of neurons with neurites greater than 30 m to 33.1% Ϯ 3.8% ( Figures 5D and 5E ) (p Ͻ the effects of the conditioning lesion are mediated at least partly by stimulation of cAMP levels in the sensory 0.0001 when compared to either control or salineinjected) and a statistically significant increase in the neurons, a possibility that needs to be directly tested. Conversely, the fact that in the saline-injected group a length of neurites ( Figure 5F ) (e.g., among neurons with neurites, the fraction with neurites greater than 150 m few fibers penetrated the lesion site (though only for 
